Publication date: Jan 15, 2025
Background: To be diagnosed and treated for cancer can be a distressing experience, and it can require individuals to engage in self-care strategies to cope with the situation. The self-care experiences of older adults with lymphoma undergoing chemotherapy during the COVID-19 pandemic in Thailand remain rarely studied. This study aimed to explore the lived experiences of self-care among older adults with lymphoma undergoing chemotherapy during the COVID-19 pandemic. Methods: A hermeneutic phenomenology research design was used. It involved in-depth interviews with nine older adults with lymphoma undergoing chemotherapy. Data analysis utilized van Manen’s approach, and trustworthiness was ensured by adhering to Lincoln and Guba’s criteria. Results: This study revealed that the lived experience of self-care among older adults with lymphoma receiving chemotherapy during the COVID-19 pandemic encompasses five lifeworlds within the lived body, addressing aspects of (1) thumjai and (2) continuing to fight cancer. Lived relations means trusting healthcare providers and holding on together. Lived time reflects being aware of the natural path of life. The concept of lived space encompasses staying safe at home and staying cautious. Lived things reflect (1) accepting one’s own karma and (2) living economically. Conclusions: The findings enhance the understanding of self-care experiences among older adults with lymphoma undergoing chemotherapy during the COVID-19 pandemic in an Asian context. The findings can inform the development of a person-centered nursing intervention tailored for older persons that emphasizes cultural aspects.
Open Access PDF
| Concepts | Keywords |
|---|---|
| Chemotherapy | cancer |
| Interviews | COVID-19 |
| Thailand | older adults |
| Trustworthiness | qualitative research |
| Van | self-care |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | Lymphoma |
| disease | MESH | COVID-19 Pandemic |
| disease | MESH | cancer |
| disease | IDO | intervention |
| drug | DRUGBANK | Coenzyme M |
| drug | DRUGBANK | Trestolone |
| disease | MESH | melanoma |
| pathway | KEGG | Melanoma |
| disease | MESH | skin cancer |
| disease | MESH | chronic illness |
| disease | MESH | COPD |
| disease | MESH | depression |
| disease | MESH | hypertension |
| disease | IDO | process |
| disease | MESH | lifestyles |
| disease | MESH | morbidity |
| disease | MESH | death |
| disease | MESH | cognitive impairment |
| disease | MESH | infection |
| disease | MESH | facial expressions |
| disease | MESH | posture |
| disease | MESH | Stroke |
| disease | MESH | intracerebral hemorrhage |
| disease | MESH | ischemic heart disease |
| disease | MESH | dyslipidemia |
| disease | MESH | diabetes mellitus |
| disease | MESH | nutritional status |
| disease | MESH | retirement |
| drug | DRUGBANK | Water |
| drug | DRUGBANK | Tropicamide |
| disease | MESH | aids |
| disease | IDO | symptom |
| disease | MESH | privacy |
| disease | MESH | Hematological malignancies |
| disease | MESH | Leukemia |
| disease | MESH | anxiety |